When it comes to peptide-related therapies, the strongest human evidence is currently in metabolic treatments such as GLP-1/GIP/glucagon agonists for weight loss, insulin resistance, and fatty liver improvement
Peripheral blood GABA levels, as measured by HPLC, do not vary significantly by gender or exercise (150)
Let's be honest, this is crucial when you're making decisions about your health
The relatively short half-life, compared with longer-acting compounds in the broader GH-axis class, is part of why Ipamorelin produces a pulsatile, physiologically patterned GH release rather than a sustained elevation, which is one of the reasons it remains a preferred reference tool for studying pulsatile GH secretion patterns
Biopsy-proven NASH : Patients with histologically confirmed NASH, particularly those with significant inflammation or early fibrosis (F1-F2), may be considered for off-label GLP-1 therapy, especially if they have failed lifestyle modification or have contraindications to other therapies like vitamin E or pioglitazone
Read more Research & Evidence Complete analysis of key studies including the 2014 retraction, LIFT-AD failure, and independent supporting data